(Q38160533)

30 August 2017

title

Epidemiology of whooping cough & typing of Bordetella pertussis (English)

1 reference

30 August 2017

1 reference

2

Nicole Guiso

1 reference

30 August 2017

Nicolas Hegerle

1

1 reference

30 August 2017

publication date

1 November 2013

1 reference

30 August 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

11

1 reference

30 August 2017

page(s)

1391-1403

1 reference

Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Update on pertussis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

The Phases of Haemophilus pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Antigenic modulation ofBordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Identification of a CO2 responsive regulon in Bordetella

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

The ins and outs of pertussis toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Structure of the Bordetella pertussis 1414 endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Pertussis vaccines: WHO position paper--recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Rationale for pertussis booster vaccination throughout life in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

The serotypes ofBordetella pertussisisolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis vaccine strains and circulating isolates in Serbia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis, Finland and France

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis isolates in Finland: serotype and fimbrial expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Multilocus sequence typing of Bordetella pertussis based on surface protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Small mutations in Bordetella pertussis are associated with selective sweeps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Bordetella pertussis and pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Pertactin-negative variants of Bordetella pertussis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Pertussis surveillance in private pediatric practices, France, 2002-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.111

21 January 2018

Identifiers

DOI

10.2217/FMB.13.111

1 reference

30 August 2017

1 reference